Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2013-03-27 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
关于公司2012年度募集资金存放与使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2012年度募集资金存放与使用情况鉴证报告" which translates to "2012 Annual Verification Report on the Deposit and Use of Raised Funds". It is issued by an accounting firm (立信会计师事务所) and includes detailed verification and audit of the company's use of funds raised through stock issuance. The document references regulatory guidelines such as the Shenzhen Stock Exchange rules and the China Securities Regulatory Commission approval. It contains detailed financial data on the raised funds, their usage, balances, and changes in investment projects. The document is a standalone audit/verification report focused on the raised funds usage, not a full annual report or earnings release. It is not a mere announcement or certification but a substantive audit report. Therefore, it fits the category of Audit Report / Information (AR). The document length (over 10,000 characters) and detailed financial data support this classification with high confidence. FY 2012
2013-03-27 Chinese
2012年度募集资金专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2012年度募集资金专项报告" which translates to "2012 Annual Special Report on the Use of Raised Funds." It details the use, management, and auditing of funds raised by the company through a public offering in 2010. The content includes audited financial figures related to the raised funds, their allocation to specific projects, compliance with regulatory requirements, and the results of an audit on the use of these funds. The document is not a full annual report (10-K), nor is it a general audit report (AR) since it focuses specifically on the use of raised funds. It is not a simple announcement or a certification but a detailed report on fundraising usage and compliance. This fits best with the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length (6951 characters) and detailed financial data support this classification with high confidence.
2013-03-27 Chinese
第四届董事会第四次会议决议的公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the fourth meeting of the fourth board of directors of 嘉事堂药业股份有限公司, held on March 26, 2013. It includes approvals of the 2012 annual board work report, financial statements, profit distribution plan, social responsibility report, amendments to company bylaws, and appointment of the CEO. The document references the 2012 annual report and other reports but does not contain the full annual report itself. It is a formal announcement of board meeting decisions, including management appointments and financial approvals, rather than the full annual report or financial statements. The document length is 3332 characters, relatively short and focused on meeting resolutions. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting resolutions and management changes, including CEO appointment.
2013-03-27 Chinese
2012年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an audit report and financial statements for the fiscal year from January 1, 2012 to December 31, 2012. It contains detailed financial statements including balance sheets, profit and loss statements, cash flow statements, and statements of changes in equity, along with an auditor's opinion. The presence of a formal auditor's report with an opinion on the financial statements indicates this is a standalone audit report. The document is comprehensive and contains actual financial data, not just an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR). FY 2012
2013-03-27 Chinese
2012年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as "嘉事堂药业股份有限公司 2012 年度报告摘要" which translates to "Cachet Pharmaceutical Co., Ltd. 2012 Annual Report Summary." It contains detailed financial data for the year 2012, including revenue, net profit, earnings per share, and shareholder information. It also includes management discussion and analysis of the company's performance during the year. The document explicitly states it is a summary of the full annual report and encourages investors to read the full report for more details. The length is 3125 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. Therefore, it is classified as an Annual Report (10-K) type document, specifically an annual report summary which falls under the Annual Report category rather than a mere announcement or regulatory filing. FY 2012
2013-03-27 Chinese
2012年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a 2012年度业绩快报, which translates to '2012 Annual Performance Express Report' or '2012 Annual Results Brief.' It contains preliminary financial data for the year 2012, including revenue, profit, net income, earnings per share, and other key financial metrics. The document explicitly states that the data is preliminary, internally audited but not yet audited by an external accounting firm, and may differ from the final annual report. It also references the 2012 third quarter report and confirms no discrepancies with the annual forecast. The document is relatively short (1447 characters) and serves as a quick announcement of preliminary annual financial results rather than a full detailed annual report. This fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. Therefore, the correct classification is Earnings Release (ER). FY 2012
2013-02-19 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.